Related Experiment Video

Updated: Aug 18, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 mutation heterogeneity in cancer

T Soussi1, G Lozano

  • 1Laboratoire de Génotoxicologie des tumeurs, EA3493 IC-UPMC, Hôpital Tenon, Dpt Pneumologie, 26 rue d'Ulm, 75005 Paris, France. thierry.soussi@free.fr

Biochemical and Biophysical Research Communications
|May 4, 2005
PubMed

Insights

The p53 tumor suppressor gene is frequently altered in human cancers, contributing to therapy resistance. Mutant p53 proteins can gain oncogenic functions, complicating cancer development and treatment strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The p53 gene is a critical tumor suppressor, frequently inactivated in approximately 50% of human cancers.
  • p53 protein plays a vital role in cellular responses to genotoxic stress from treatments like radiotherapy and chemotherapy.
  • Alterations in p53 are strongly implicated in tumor resistance to cancer therapies.

Purpose of the Study:

  • To investigate the role of p53 gene alterations in cancer development and therapy resistance.
  • To understand the functional heterogeneity and oncogenic potential of mutant p53 proteins.
  • To explore the complex relationship between p53 inactivation and neoplasia, including the dissociation of its functions.

Main Methods:

  • Analysis of p53 gene status in human cancers.
  • Characterization of missense mutations in p53 and their functional consequences.
  • Assessment of p53 mutant protein activity in cell transformation, apoptosis, and proliferation.

Main Results:

  • p53 gene inactivation is a common event in human cancers, particularly through missense mutations (80%).
  • Mutant p53 proteins exhibit functional heterogeneity and can acquire oncogenic properties.
  • Specific p53 mutants demonstrate dissociation between apoptotic and anti-proliferative functions.

Conclusions:

  • p53 alterations are key drivers of tumor resistance to therapy.
  • Mutant p53 proteins actively contribute to cancer development through oncogenic functions.
  • The complex nature of p53 mutations, including functional dissociation, adds layers to understanding cancer biology and therapeutic strategies.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence07:54

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence

Published on: October 25, 2011

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...